ReviewCureus2026
Oral Myiasis: A Structured Review of Risk Factors, Clinical Presentation, and Treatment.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral myiasis is an uncommon parasitic infestation caused by dipteran larvae that invade living or necrotic oral tissues, and it is associated with poor oral hygiene, periodontal disease, neurological or psychiatric disability, malignancy, and social vulnerability. This structured review aimed to characterize the risk factors, clinical presentation, and therapeutic alternatives for strictly oral myiasis. A literature search was conducted in PubMed/MEDLINE, SciELO, and Scopus to identify case reports and case series involving humans with disease restricted to the oral cavity, published in Spanish or English between 2000 and 2026. To focus on contemporary evidence, only cases published from 2020 onward were included. Fourteen primary studies were analyzed. There was a slight male predominance, and the patients ranged from a five-month-old infant to a 91-year-old adult, with most presenting a neurological, psychiatric, or oncological predisposing condition. The most frequently affected sites were the anterior maxilla and the palate. In most reports, the larva was not identified to the species level; when identified, the agents were Chrysomya bezziana, Musca domestica, and Sarcophaga ruficornis. Management was consistently multimodal, combining mechanical removal of larvae with systemic antibiotics, antiparasitic therapy (ivermectin), surgical debridement, and topical agents. Oral myiasis mainly affects medically and socially vulnerable patients and can be life-threatening in critically ill hosts; its management requires a multidisciplinary approach, and awareness among healthcare professionals is essential for early diagnosis and reducing associated morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.